XZMJ:XETRA:XETRA-Xtrackers ESG MSCI Japan UCITS 1C EUR (EUR)

ETF | Others |

Last Closing

USD 21.95

Change

+0.27 (+1.25)%

Market Cap

USD 2.01B

Volume

0.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing XZMJ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.32% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.32% 74% C 73% C
Trailing 12 Months  
Capital Gain 25.10% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.10% 72% C 71% C-
Trailing 5 Years  
Capital Gain 39.01% 55% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.01% 54% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 5.86% N/A N/A 53% F
Dividend Return 5.86% N/A N/A 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.02% N/A N/A 60% D-
Risk Adjusted Return 48.76% N/A N/A 56% F
Market Capitalization 2.01B 87% B+ 77% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike